PMC:7307149 / 10153-11401 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T61","span":{"begin":107,"end":110},"obj":"Body_part"},{"id":"T62","span":{"begin":210,"end":213},"obj":"Body_part"},{"id":"T63","span":{"begin":408,"end":411},"obj":"Body_part"},{"id":"T64","span":{"begin":421,"end":424},"obj":"Body_part"},{"id":"T65","span":{"begin":438,"end":441},"obj":"Body_part"},{"id":"T66","span":{"begin":535,"end":538},"obj":"Body_part"},{"id":"T67","span":{"begin":781,"end":784},"obj":"Body_part"},{"id":"T68","span":{"begin":913,"end":916},"obj":"Body_part"},{"id":"T69","span":{"begin":1080,"end":1083},"obj":"Body_part"}],"attributes":[{"id":"A61","pred":"fma_id","subj":"T61","obj":"http://purl.org/sig/ont/fma/fma84079"},{"id":"A62","pred":"fma_id","subj":"T62","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A63","pred":"fma_id","subj":"T63","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A64","pred":"fma_id","subj":"T64","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A65","pred":"fma_id","subj":"T65","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A66","pred":"fma_id","subj":"T66","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A67","pred":"fma_id","subj":"T67","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A68","pred":"fma_id","subj":"T68","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A69","pred":"fma_id","subj":"T69","obj":"http://purl.org/sig/ont/fma/fma84079"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T57","span":{"begin":296,"end":304},"obj":"Disease"},{"id":"T58","span":{"begin":626,"end":634},"obj":"Disease"},{"id":"T59","span":{"begin":1042,"end":1050},"obj":"Disease"}],"attributes":[{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A59","pred":"mondo_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T103","span":{"begin":53,"end":61},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T104","span":{"begin":214,"end":215},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T105","span":{"begin":218,"end":219},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T106","span":{"begin":376,"end":384},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T107","span":{"begin":412,"end":413},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T108","span":{"begin":425,"end":426},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T109","span":{"begin":487,"end":495},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T110","span":{"begin":637,"end":645},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T111","span":{"begin":658,"end":659},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T112","span":{"begin":731,"end":736},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T113","span":{"begin":785,"end":786},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T114","span":{"begin":872,"end":879},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T115","span":{"begin":1113,"end":1114},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T116","span":{"begin":1228,"end":1232},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T117","span":{"begin":1244,"end":1246},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T118","span":{"begin":1244,"end":1246},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T52","span":{"begin":53,"end":61},"obj":"Chemical"},{"id":"T53","span":{"begin":119,"end":126},"obj":"Chemical"},{"id":"T54","span":{"begin":251,"end":253},"obj":"Chemical"},{"id":"T55","span":{"begin":376,"end":384},"obj":"Chemical"},{"id":"T56","span":{"begin":487,"end":495},"obj":"Chemical"},{"id":"T57","span":{"begin":637,"end":645},"obj":"Chemical"},{"id":"T58","span":{"begin":872,"end":879},"obj":"Chemical"},{"id":"T59","span":{"begin":1244,"end":1246},"obj":"Chemical"}],"attributes":[{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_29388"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A58","pred":"chebi_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A59","pred":"chebi_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"220","span":{"begin":107,"end":126},"obj":"Gene"},{"id":"221","span":{"begin":210,"end":227},"obj":"Gene"},{"id":"222","span":{"begin":408,"end":413},"obj":"Gene"},{"id":"223","span":{"begin":421,"end":426},"obj":"Gene"},{"id":"224","span":{"begin":781,"end":786},"obj":"Gene"},{"id":"225","span":{"begin":438,"end":443},"obj":"Gene"},{"id":"226","span":{"begin":296,"end":306},"obj":"Species"},{"id":"227","span":{"begin":626,"end":636},"obj":"Species"},{"id":"228","span":{"begin":731,"end":736},"obj":"Species"},{"id":"229","span":{"begin":737,"end":750},"obj":"Species"},{"id":"230","span":{"begin":1042,"end":1052},"obj":"Species"},{"id":"231","span":{"begin":1181,"end":1192},"obj":"Species"}],"attributes":[{"id":"A220","pred":"tao:has_database_id","subj":"220","obj":"Gene:100507703"},{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"Gene:3105"},{"id":"A222","pred":"tao:has_database_id","subj":"222","obj":"Gene:3105"},{"id":"A223","pred":"tao:has_database_id","subj":"223","obj":"Gene:3106"},{"id":"A224","pred":"tao:has_database_id","subj":"224","obj":"Gene:3106"},{"id":"A225","pred":"tao:has_database_id","subj":"225","obj":"Gene:3107"},{"id":"A226","pred":"tao:has_database_id","subj":"226","obj":"Tax:2697049"},{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"Tax:2697049"},{"id":"A228","pred":"tao:has_database_id","subj":"228","obj":"Tax:9606"},{"id":"A229","pred":"tao:has_database_id","subj":"229","obj":"Tax:11118"},{"id":"A230","pred":"tao:has_database_id","subj":"230","obj":"Tax:2697049"},{"id":"A231","pred":"tao:has_database_id","subj":"231","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T15","span":{"begin":107,"end":110},"obj":"http://purl.obolibrary.org/obo/GO_0046776"},{"id":"T16","span":{"begin":119,"end":137},"obj":"http://purl.obolibrary.org/obo/GO_0019882"},{"id":"T17","span":{"begin":1080,"end":1083},"obj":"http://purl.obolibrary.org/obo/GO_0046776"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}

    LitCovid-PD-GlycoEpitope

    {"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T2","span":{"begin":117,"end":126},"obj":"GlycoEpitope"}],"attributes":[{"id":"A2","pred":"glyco_epitope_db_id","subj":"T2","obj":"http://www.glycoepitope.jp/epitopes/EP0138"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T62","span":{"begin":256,"end":385},"obj":"Sentence"},{"id":"T63","span":{"begin":386,"end":496},"obj":"Sentence"},{"id":"T64","span":{"begin":497,"end":751},"obj":"Sentence"},{"id":"T65","span":{"begin":752,"end":817},"obj":"Sentence"},{"id":"T66","span":{"begin":818,"end":962},"obj":"Sentence"},{"id":"T67","span":{"begin":963,"end":1248},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"For the subset of these potentially cross-protective peptides that are anticipated to be generated via the MHC class I antigen processing pathway, we performed binding affinity predictions across 145 different HLA-A, -B, and -C alleles (see Data File S3). As described above, we demonstrated the SARS-CoV-2-specific distribution of per-allele presentation for these conserved peptides. We found that alleles HLA-A*02:02, HLA-B*15:03, and HLA-C*12:03 were the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other human coronaviruses. We note, in particular, that HLA-B*46:01 was among these alleles. We note also that the putative capacity for conserved peptide presentation is unrelated to the HLA allelic frequency in the population (Fig. 3). Moreover, we see no appreciable global correlation between conservation of the SARS-CoV-2 proteome and its predicted MHC binding affinity, suggesting a lack of selective pressure for or against the capacity to present coronavirus epitopes (P = 0.27 [Fisher’s exact test]; see Fig. S2)."}